« Back
Home /
Dalbavancin HCl

Dalbavancin HCl

Manufacturer	TargetMol
Category	Molecule
Type	Molecules
Specific against	other
Amount	50mg
Item no.	TMO-T21358-50mg
Approximate Leadtime	1-2 Weeks
eClass 6.1	32169090
eClass 9.0	32169090
Available
purity	98.00%
formula	C88H101Cl3N10O28
MolWt	1853.17
Pathway	Microbiology/Virology
Target	Antibiotic
Bioactivity	Dalbavancin, a novel second-generation lipoglycopeptide antibiotic, possesses in vitro activity against a variety of Gram-positive pathogens including methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE), Dalbavancin hydrochloride inhibits Staphylococcus aureus and Bacillus anthracis with MIC90s of 0.06 ug/mL and 0.25 ug/mL, respectively
Reference	Scoble PJ, Owens RC Jr, Puttagunta S, Yen M, Dunne MW. Pharmacokinetics, Safety, and Tolerability of a Single 500-mg or 1000-mg Intravenous Dose of Dalbavancin in Healthy Japanese Subjects. Clin Drug Investig. 2015 Oct 12. [Epub ahead of print] PubMed PMID: 26458939.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 50mg

available

Quantity:

Compare

Add to wishlist

Recommend by mail

Request delivery time

Ask a technical question